MedPath

Prevention of Surgical Wound Infection

Not Applicable
Conditions
Cardiac Surgery
Registration Number
NCT03905213
Lead Sponsor
Maria Jesus Perez
Brief Summary

To compare cost effectiveness of a polyurethane dressing or a vacuum therapy dressing versus the conventional gauze in the prevention of superficial wound infection y major cardiac surgery

Detailed Description

It is a clinical prospective and randomized study. patientes will be randomized to three groups on the day of surgery: conventional gauze, polyurethane or vacuum therapy dressing. Clinical al microbiological data will be monitorized to evaluate the infection rate of surgical wound , mediastinitis, days of hospital stay and consumption of antimicrobials.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
900
Inclusion Criteria
  • patient scheduled to cardiac surgery.
  • signed informed consent form
Exclusion Criteria
  • hypersensibility to dressings

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
prevention of surgical wound infectionsurgery date up to 6 months

surgical wound infection measured as number of patients suffering surgical wound infection during the study period

Secondary Outcome Measures
NameTimeMethod
hospital stayfrom hospitalization until an average of 1 year

days at hospital

dressing consumption costfrom surgery date until an average of 8 weeks

number of dressing and its cost

antimicrobial consumptionfrom surgery date until an average of 1 year

defined dose of antimicrobial agents during hospital stay

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.